SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001308411-13-000109
Filing Date
2013-05-06
Accepted
2013-05-03 19:16:37
Documents
7
Period of Report
2013-01-31

Document Format Files

Seq Description Document Type Size
1 TAMIR BIOTECHNOLOGY, INC. FORM 10/A NO. 1 acel10qa1130131.htm 10-Q/A 17379
  Complete submission text file 0001308411-13-000109.txt   1809360

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE acel-20130131.xml EX-101.INS 248774
3 XBRL SCHEMA FILE acel-20130131.xsd EX-101.SCH 15411
4 XBRL CALCULATION FILE acel-20130131_cal.xml EX-101.CAL 36133
5 XBRL DEFINITION FILE acel-20130131_def.xml EX-101.DEF 11552
6 XBRL LABEL FILE acel-20130131_lab.xml EX-101.LAB 139222
7 XBRL PRESENTATION FILE acel-20130131_pre.xml EX-101.PRE 98325
Mailing Address 300 ATRIUM DRIVE SOMERSET NJ 08873
Business Address 300 ATRIUM DRIVE SOMERSET NJ 08873 732-652-4525
Tamir Biotechnology, Inc. (Filer) CIK: 0000708717 (see all company filings)

IRS No.: 222369085 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-11088 | Film No.: 13814162
SIC: 2836 Biological Products, (No Diagnostic Substances)